• Slide title

    Empower your research with Pharmidex, a leading CRO offering advanced solutions in Bioanalysis (GLP/GCP), CNS, DMPK, Oncology, Immunology, Respiratory, and Toxicology (GLP).

    Button

  • Slide title

    Unlock the full potential of your research with Pharmidex, your trusted partner in drug discovery, offering unparalleled expertise and innovative solutions to drive your projects toward success.

    Button

Service Offerings

Therapeutic Areas

Services By Developmental Phase

Latest News

Who We Are

About us

Pharmidex is a contract research organisation (CRO) that provides translational solutions using its world-renowned expertise in CNS, oncology, respiratory, DMPK, drug discovery and ADMET/pharmacokinetics.


Founded in the UK, in 2002, Pharmidex operates in state-of-the-art facilities in Hertfordshire to provide high-quality experimental data and expert guidance to support drug discovery and development.

Key Facts

Experts in therapeutic preclinical models 


Accredited by AAALAC and the MHRA to perform GLP and GCP certified services

Services

Single site service offering with 15,000+ studies conducted to date


Quick turnaround times, cost effective research, expert interpretation and customer-focused approach

Our History

Successfully helped multiple clients reach clinical development since 2002

News

DMPK Services News!

🎄✨ Thank You from Pharmidex! ✨🎄

December 19, 2024
As the year comes to a close, everyone at Pharmidex would like to take this opportunity to express our heartfelt gratitude for your trust, support, and partnership. We wish you a healthy, happy, and prosperous new year ahead! 🌟 In keeping with our tradition, we are proud to support charities that make a meaningful difference in people's lives. Here's to another year of collaboration and innovation together!

🌟 Pharmidex is proud to attend the Creative Disruption Forum! 🌟

December 11, 2024
We are excited to participate in the Creative Disruption Forum: How Tech is Changing Small Molecule Drug Hunting, taking place on Thursday, 12 December at MAYDE, 5-10 Brandon Road, London N7 9AA. Representing Pharmidex will be our Head of Operations, Ash Alavijeh , and Mohammed Yaqoob , from Business Development. They are looking forward to engaging with all attendees to explore opportunities for future collaborations with companies, research groups, and universities. This forum is an incredible opportunity to connect, share ideas, and discuss how technological innovation is revolutionizing small molecule drug discovery. Let’s shape the future of science together! 🚀 We would be delighted to meet you there. Feel free to reach out or stop by for a chat!
Services by Department
Share by: